Move at the Speed of Experience™
Optimizing commercial readiness to drive value, accelerate time to market and maximize revenue potential.
Engage an experienced and cross-functional team able to be fully operational within days.
Employ a holistic approach spanning strategy through execution.
Scale your commercial organization while simultaneously working to prepare the market.
Mitigate risk associated with a suboptimal launch.
Our Operational Philosophy.
ReCiPe™ is designed to rapidly accelerate commercialization for clinical-stage biotech companies through the creation of strategic efficiencies and excellence in execution. Utilizing an integrated approach beginning with evidence-based insights through to strategy development and implementation, ReCiPe™ can be applied at any point along the commercialization continuum.
Strategic excellence.
Expert execution.
"Efficiency and results are the natural
outcome of expertise and practical
knowledge."
Christina Ansted, MPH, CCMEP
Chief Executive Officer
- Rare Disease and Gene Therapy
- Unbiased Commercial Viability
- Pre-Clinical to Phase III
- Commercial Development
- Valuation for Potential Investors
- Commercial Operations
- Strategic Market Preparation
- Market and Patient Access
- Payer Value Story Development
- Patient Services
- KOL/Key Investigator Development
- Patient Identification/Diagnostics
- Market Analytics
- Vendor Management
- Stakeholder Engagement
- Patient Journey